PULMONX CORPORATION— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$129M
↓-20.6% -$34Mvs FY2024
Total Liabilities
$75M
↓-2.4% -$2Mvs FY2024
Equity
$54M
↓-36.9% -$32Mvs FY2024
Cash
$70M
↓-1.6% -$1Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $129M | $163M |
| Current Assets | $102M | $136M |
| Cash | $70M | $71M |
| ST Investments | $0 | $0 |
| Receivables | $12M | $13M |
| Inventory | $16M | $17M |
| Other Current | $4M | $35M |
| Non-Current Assets | $28M | $27M |
| PPE | $2M | $3M |
| Goodwill | $2M | $2M |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $23M | $21M |
| Total Liab+Eq | $129M | $163M |
| Current Liab. | $20M | $24M |
| Accounts Payable | $4M | $4M |
| Short-Term Debt | $106K | $3M |
| Deferred Revenue | $18K | $135K |
| Other CL | $16M | $17M |
| Non-Current Liab. | $55M | $53M |
| Long-Term Debt | $37M | $34M |
| Other LT Liab. | $18M | $19M |
| Equity | $54M | $86M |
| Retained Earnings | $522M | $468M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · LUNG · Comparing FY2025 vs FY2024